Clinical Edge Journal Scan

Meta-analysis evaluates risk for migraine among patients with multiple sclerosis


 

Key clinical point: Nearly 24% of patients with multiple sclerosis (MS) experience migraine, with the odds of migraine occurrence being approximately 2-fold higher in patients with MS compared with control individuals.

Major finding: The overall prevalence rate of migraine among patients with MS was 0.24 (95% CI 0.21 -0.28). Moreover, patients with MS vs control participants without MS had a ~2-fold greater risk of experiencing migraine (odds ratio 1.96; 95% CI 1.20 -3.20).

Study details: This meta-analysis of 35 studies included 279,620 patients with MS and 279,603 control participants without MS.

Disclosures: This study did not receive any funding. The authors declared no conflicts of interest.

Source: Mohammadi M et al. The association between multiple sclerosis and migraine: A meta-analysis. Mult Scler Relat Disord. 2023;79:104954 (Aug 30). doi: 10.1016/j.msard.2023.104954

Recommended Reading

Migraine tied to a greater risk for rheumatoid arthritis
Migraine ICYMI
Higher dietary zinc intake and risk for migraine: Is there a link?
Migraine ICYMI
Severe obesity and postmenopausal status associated with increased migraine frequency
Migraine ICYMI
Commentary: Looking at CGRP medications for migraine, September 2023
Migraine ICYMI
Is ‘growing pain’ during childhood an early indicator of migraine?
Migraine ICYMI
Effect of COVID-19 infection or vaccination on migraine frequency
Migraine ICYMI
Ubrogepant shows similar efficacy for perimenstrual and non-perimenstrual migraine attacks
Migraine ICYMI
Early wearing-off effect in patients treated with onabotulinumtoxinA for chronic migraine
Migraine ICYMI
Migraine history raises risk for cervical artery dissection
Migraine ICYMI
Cutaneous allodynia predicts treatment response in patients with chronic migraine and medication overuse
Migraine ICYMI